The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Large Volume Parenteral (LVP) Market Research Report 2022

Global Large Volume Parenteral (LVP) Market Research Report 2022

Publishing Date : Jun, 2022

License Type :
 

Report Code : 1415847

No of Pages : 107

Synopsis
Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.
Due to the COVID-19 pandemic, the global Large Volume Parenteral (LVP) market size is estimated to be worth US$ 10530 million in 2021 and is forecast to a readjusted size of US$ 14000 million by 2028 with a CAGR of 4.1% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Large Volume Parenteral (LVP) market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Large Volume Parenteral (LVP) landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The main Large Volume Parenteral (LVP) players include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, etc. The top five Large Volume Parenteral (LVP) players account for approximately 66% of the total global market. Asia-Pacific is the largest consumer market for Large Volume Parenteral (LVP) accounting for about 47%, followed by Europe and North America. In terms of Type, Soft Bag LVP is the largest segment, with a share about 56%. And in terms of Application, the largest application is Therapeutic Infusion, followed by Basic Infusion.
This report focuses on Large Volume Parenteral (LVP) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Large Volume Parenteral (LVP) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, Middle East&Africa and India, etc.
Global Large Volume Parenteral (LVP) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type

  • Soft Bag LVP
  • Plastic Bottle LVP
  • Glass Bottle LVP

Segment by Application

  • Basic Infusion
  • Therapeutic Infusion
  • Nutritious Infusion

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Baxter Healthcare
  • Kelun Pharma
  • B. Braun
  • Fresenius
  • Teva Pharmaceutical Industries
  • Pfizer (Hospira)
  • Ostuka Pharmaceutical
  • CR Double-Crane
  • Pisa
  • Huaren
  • Patheon
  • Beximco Pharma
  • Albert David
  • PSI Ltd
  • Ozon Pharmaceuticals
  • BAG Healthcare
  • BML Parenteral Drugs
Index

1 Large Volume Parenteral (LVP) Market Overview
1.1 Product Overview and Scope of Large Volume Parenteral (LVP)
1.2 Large Volume Parenteral (LVP) Segment by Type
1.2.1 Global Large Volume Parenteral (LVP) Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
1.3 Large Volume Parenteral (LVP) Segment by Application
1.3.1 Global Large Volume Parenteral (LVP) Sales Comparison by Application: (2022-2028)
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Global Large Volume Parenteral (LVP) Market Size Estimates and Forecasts
1.4.1 Global Large Volume Parenteral (LVP) Revenue 2017-2028
1.4.2 Global Large Volume Parenteral (LVP) Sales 2017-2028
1.4.3 Large Volume Parenteral (LVP) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Large Volume Parenteral (LVP) Market Competition by Manufacturers
2.1 Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2017-2022)
2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Large Volume Parenteral (LVP) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites, Area Served, Product Type
2.5 Large Volume Parenteral (LVP) Market Competitive Situation and Trends
2.5.1 Large Volume Parenteral (LVP) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Large Volume Parenteral (LVP) Players Market Share by Revenue
2.5.3 Global Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Large Volume Parenteral (LVP) Retrospective Market Scenario by Region
3.1 Global Large Volume Parenteral (LVP) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Large Volume Parenteral (LVP) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.3.1 North America Large Volume Parenteral (LVP) Sales by Country
3.3.2 North America Large Volume Parenteral (LVP) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.4.1 Europe Large Volume Parenteral (LVP) Sales by Country
3.4.2 Europe Large Volume Parenteral (LVP) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Large Volume Parenteral (LVP) Market Facts & Figures by Region
3.5.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Region
3.5.2 Asia Pacific Large Volume Parenteral (LVP) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.6.1 Latin America Large Volume Parenteral (LVP) Sales by Country
3.6.2 Latin America Large Volume Parenteral (LVP) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.7.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country
3.7.2 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Large Volume Parenteral (LVP) Historic Market Analysis by Type
4.1 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2017-2022)
4.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2017-2022)
4.3 Global Large Volume Parenteral (LVP) Price by Type (2017-2022)
5 Global Large Volume Parenteral (LVP) Historic Market Analysis by Application
5.1 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2017-2022)
5.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2017-2022)
5.3 Global Large Volume Parenteral (LVP) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Baxter Healthcare
6.1.1 Baxter Healthcare Corporation Information
6.1.2 Baxter Healthcare Description and Business Overview
6.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.1.5 Baxter Healthcare Recent Developments/Updates
6.2 Kelun Pharma
6.2.1 Kelun Pharma Corporation Information
6.2.2 Kelun Pharma Description and Business Overview
6.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio
6.2.5 Kelun Pharma Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Corporation Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 B. Braun Large Volume Parenteral (LVP) Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Fresenius
6.4.1 Fresenius Corporation Information
6.4.2 Fresenius Description and Business Overview
6.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Fresenius Large Volume Parenteral (LVP) Product Portfolio
6.4.5 Fresenius Recent Developments/Updates
6.5 Teva Pharmaceutical Industries
6.5.1 Teva Pharmaceutical Industries Corporation Information
6.5.2 Teva Pharmaceutical Industries Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio
6.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.6 Pfizer (Hospira)
6.6.1 Pfizer (Hospira) Corporation Information
6.6.2 Pfizer (Hospira) Description and Business Overview
6.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio
6.6.5 Pfizer (Hospira) Recent Developments/Updates
6.7 Ostuka Pharmaceutical
6.6.1 Ostuka Pharmaceutical Corporation Information
6.6.2 Ostuka Pharmaceutical Description and Business Overview
6.6.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
6.7.5 Ostuka Pharmaceutical Recent Developments/Updates
6.8 CR Double-Crane
6.8.1 CR Double-Crane Corporation Information
6.8.2 CR Double-Crane Description and Business Overview
6.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.8.4 CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio
6.8.5 CR Double-Crane Recent Developments/Updates
6.9 Pisa
6.9.1 Pisa Corporation Information
6.9.2 Pisa Description and Business Overview
6.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Pisa Large Volume Parenteral (LVP) Product Portfolio
6.9.5 Pisa Recent Developments/Updates
6.10 Huaren
6.10.1 Huaren Corporation Information
6.10.2 Huaren Description and Business Overview
6.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Huaren Large Volume Parenteral (LVP) Product Portfolio
6.10.5 Huaren Recent Developments/Updates
6.11 Patheon
6.11.1 Patheon Corporation Information
6.11.2 Patheon Large Volume Parenteral (LVP) Description and Business Overview
6.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Patheon Large Volume Parenteral (LVP) Product Portfolio
6.11.5 Patheon Recent Developments/Updates
6.12 Beximco Pharma
6.12.1 Beximco Pharma Corporation Information
6.12.2 Beximco Pharma Large Volume Parenteral (LVP) Description and Business Overview
6.12.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
6.12.5 Beximco Pharma Recent Developments/Updates
6.13 Albert David
6.13.1 Albert David Corporation Information
6.13.2 Albert David Large Volume Parenteral (LVP) Description and Business Overview
6.13.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Albert David Large Volume Parenteral (LVP) Product Portfolio
6.13.5 Albert David Recent Developments/Updates
6.14 PSI Ltd
6.14.1 PSI Ltd Corporation Information
6.14.2 PSI Ltd Large Volume Parenteral (LVP) Description and Business Overview
6.14.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.14.4 PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
6.14.5 PSI Ltd Recent Developments/Updates
6.15 Ozon Pharmaceuticals
6.15.1 Ozon Pharmaceuticals Corporation Information
6.15.2 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Description and Business Overview
6.15.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
6.15.5 Ozon Pharmaceuticals Recent Developments/Updates
6.16 BAG Healthcare
6.16.1 BAG Healthcare Corporation Information
6.16.2 BAG Healthcare Large Volume Parenteral (LVP) Description and Business Overview
6.16.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.16.4 BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.16.5 BAG Healthcare Recent Developments/Updates
6.17 BML Parenteral Drugs
6.17.1 BML Parenteral Drugs Corporation Information
6.17.2 BML Parenteral Drugs Large Volume Parenteral (LVP) Description and Business Overview
6.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2017-2022)
6.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
6.17.5 BML Parenteral Drugs Recent Developments/Updates
7 Large Volume Parenteral (LVP) Manufacturing Cost Analysis
7.1 Large Volume Parenteral (LVP) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Large Volume Parenteral (LVP)
7.4 Large Volume Parenteral (LVP) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Large Volume Parenteral (LVP) Distributors List
8.3 Large Volume Parenteral (LVP) Customers
9 Large Volume Parenteral (LVP) Market Dynamics
9.1 Large Volume Parenteral (LVP) Industry Trends
9.2 Large Volume Parenteral (LVP) Market Drivers
9.3 Large Volume Parenteral (LVP) Market Challenges
9.4 Large Volume Parenteral (LVP) Market Restraints
10 Global Market Forecast
10.1 Large Volume Parenteral (LVP) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Type (2023-2028)
10.2 Large Volume Parenteral (LVP) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Application (2023-2028)
10.3 Large Volume Parenteral (LVP) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Large Volume Parenteral (LVP) Sales Growth Rate Comparison by Type (2022-2028) & (M Units) & (US$ Million)
Table 2. Global Large Volume Parenteral (LVP) Sales Growth Rate Comparison by Application (2022-2028) & (M Units) & (US$ Million)
Table 3. Global Large Volume Parenteral (LVP) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Large Volume Parenteral (LVP) Market Competitive Situation by Manufacturers in 2021
Table 5. Global Large Volume Parenteral (LVP) Sales (M Units) of Key Manufacturers (2017-2022)
Table 6. Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Large Volume Parenteral (LVP) Average Price (US$/K Units) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites and Area Served
Table 11. Manufacturers Large Volume Parenteral (LVP) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Large Volume Parenteral (LVP) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Large Volume Parenteral (LVP) as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Large Volume Parenteral (LVP) Sales by Region (2017-2022) & (M Units)
Table 16. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2017-2022)
Table 17. Global Large Volume Parenteral (LVP) Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2017-2022)
Table 19. North America Large Volume Parenteral (LVP) Sales by Country (2017-2022) & (M Units)
Table 20. North America Large Volume Parenteral (LVP) Sales Market Share by Country (2017-2022)
Table 21. North America Large Volume Parenteral (LVP) Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Large Volume Parenteral (LVP) Revenue Market Share by Country (2017-2022)
Table 23. Europe Large Volume Parenteral (LVP) Sales by Country (2017-2022) & (M Units)
Table 24. Europe Large Volume Parenteral (LVP) Sales Market Share by Country (2017-2022)
Table 25. Europe Large Volume Parenteral (LVP) Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Large Volume Parenteral (LVP) Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2017-2022) & (M Units)
Table 28. Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Region (2017-2022)
Table 31. Latin America Large Volume Parenteral (LVP) Sales by Country (2017-2022) & (M Units)
Table 32. Latin America Large Volume Parenteral (LVP) Sales Market Share by Country (2017-2022)
Table 33. Latin America Large Volume Parenteral (LVP) Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Large Volume Parenteral (LVP) Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2017-2022) & (M Units)
Table 36. Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Large Volume Parenteral (LVP) Revenue Market Share by Country (2017-2022)
Table 39. Global Large Volume Parenteral (LVP) Sales by Type (2017-2022) & (M Units)
Table 40. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2017-2022)
Table 41. Global Large Volume Parenteral (LVP) Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Large Volume Parenteral (LVP) Revenue Share by Type (2017-2022)
Table 43. Global Large Volume Parenteral (LVP) Price by Type (2017-2022) & (US$/K Units)
Table 44. Global Large Volume Parenteral (LVP) Sales (M Units) by Application (2017-2022)
Table 45. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2017-2022)
Table 46. Global Large Volume Parenteral (LVP) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Large Volume Parenteral (LVP) Revenue Share by Application (2017-2022)
Table 48. Global Large Volume Parenteral (LVP) Price by Application (2017-2022) & (US$/K Units)
Table 49. Baxter Healthcare Corporation Information
Table 50. Baxter Healthcare Description and Business Overview
Table 51. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 52. Baxter Healthcare Large Volume Parenteral (LVP) Product
Table 53. Baxter Healthcare Recent Developments/Updates
Table 54. Kelun Pharma Corporation Information
Table 55. Kelun Pharma Description and Business Overview
Table 56. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 57. Kelun Pharma Large Volume Parenteral (LVP) Product
Table 58. Kelun Pharma Recent Developments/Updates
Table 59. B. Braun Corporation Information
Table 60. B. Braun Description and Business Overview
Table 61. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 62. B. Braun Large Volume Parenteral (LVP) Product
Table 63. B. Braun Recent Developments/Updates
Table 64. Fresenius Corporation Information
Table 65. Fresenius Description and Business Overview
Table 66. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 67. Fresenius Large Volume Parenteral (LVP) Product
Table 68. Fresenius Recent Developments/Updates
Table 69. Teva Pharmaceutical Industries Corporation Information
Table 70. Teva Pharmaceutical Industries Description and Business Overview
Table 71. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 72. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product
Table 73. Teva Pharmaceutical Industries Recent Developments/Updates
Table 74. Pfizer (Hospira) Corporation Information
Table 75. Pfizer (Hospira) Description and Business Overview
Table 76. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 77. Pfizer (Hospira) Large Volume Parenteral (LVP) Product
Table 78. Pfizer (Hospira) Recent Developments/Updates
Table 79. Ostuka Pharmaceutical Corporation Information
Table 80. Ostuka Pharmaceutical Description and Business Overview
Table 81. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 82. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product
Table 83. Ostuka Pharmaceutical Recent Developments/Updates
Table 84. CR Double-Crane Corporation Information
Table 85. CR Double-Crane Description and Business Overview
Table 86. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 87. CR Double-Crane Large Volume Parenteral (LVP) Product
Table 88. CR Double-Crane Recent Developments/Updates
Table 89. Pisa Corporation Information
Table 90. Pisa Description and Business Overview
Table 91. Pisa Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 92. Pisa Large Volume Parenteral (LVP) Product
Table 93. Pisa Recent Developments/Updates
Table 94. Huaren Corporation Information
Table 95. Huaren Description and Business Overview
Table 96. Huaren Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 97. Huaren Large Volume Parenteral (LVP) Product
Table 98. Huaren Recent Developments/Updates
Table 99. Patheon Corporation Information
Table 100. Patheon Description and Business Overview
Table 101. Patheon Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 102. Patheon Large Volume Parenteral (LVP) Product
Table 103. Patheon Recent Developments/Updates
Table 104. Beximco Pharma Corporation Information
Table 105. Beximco Pharma Description and Business Overview
Table 106. Beximco Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 107. Beximco Pharma Large Volume Parenteral (LVP) Product
Table 108. Beximco Pharma Recent Developments/Updates
Table 109. Albert David Corporation Information
Table 110. Albert David Description and Business Overview
Table 111. Albert David Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 112. Albert David Large Volume Parenteral (LVP) Product
Table 113. Albert David Recent Developments/Updates
Table 114. PSI Ltd Corporation Information
Table 115. PSI Ltd Description and Business Overview
Table 116. PSI Ltd Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 117. PSI Ltd Large Volume Parenteral (LVP) Product
Table 118. PSI Ltd Recent Developments/Updates
Table 119. Ozon Pharmaceuticals Corporation Information
Table 120. Ozon Pharmaceuticals Description and Business Overview
Table 121. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 122. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product
Table 123. Ozon Pharmaceuticals Recent Developments/Updates
Table 124. BAG Healthcare Corporation Information
Table 125. BAG Healthcare Description and Business Overview
Table 126. BAG Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 127. BAG Healthcare Large Volume Parenteral (LVP) Product
Table 128. BAG Healthcare Recent Developments/Updates
Table 129. BML Parenteral Drugs Corporation Information
Table 130. BML Parenteral Drugs Description and Business Overview
Table 131. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 132. BML Parenteral Drugs Large Volume Parenteral (LVP) Product
Table 133. BML Parenteral Drugs Recent Developments/Updates
Table 134. Production Base and Market Concentration Rate of Raw Material
Table 135. Key Suppliers of Raw Materials
Table 136. Large Volume Parenteral (LVP) Distributors List
Table 137. Large Volume Parenteral (LVP) Customers List
Table 138. Large Volume Parenteral (LVP) Market Trends
Table 139. Large Volume Parenteral (LVP) Market Drivers
Table 140. Large Volume Parenteral (LVP) Market Challenges
Table 141. Large Volume Parenteral (LVP) Market Restraints
Table 142. Global Large Volume Parenteral (LVP) Sales Forecast by Type (2023-2028) & (M Units)
Table 143. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Type (2023-2028)
Table 144. Global Large Volume Parenteral (LVP) Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 145. Global Large Volume Parenteral (LVP) Revenue Market Share Forecast by Type (2023-2028)
Table 146. Global Large Volume Parenteral (LVP) Sales Forecast by Application (2023-2028) & (M Units)
Table 147. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Application (2023-2028)
Table 148. Global Large Volume Parenteral (LVP) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 149. Global Large Volume Parenteral (LVP) Revenue Market Share Forecast by Application (2023-2028)
Table 150. Global Large Volume Parenteral (LVP) Sales Forecast by Region (2023-2028) & (M Units)
Table 151. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Region (2023-2028)
Table 152. Global Large Volume Parenteral (LVP) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 153. Global Large Volume Parenteral (LVP) Revenue Market Share Forecast by Region (2023-2028)
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Large Volume Parenteral (LVP)
Figure 2. Global Large Volume Parenteral (LVP) Market Share by Type in 2021 & 2028
Figure 3. Soft Bag LVP Product Picture
Figure 4. Plastic Bottle LVP Product Picture
Figure 5. Glass Bottle LVP Product Picture
Figure 6. Global Large Volume Parenteral (LVP) Market Share by Application in 2021 & 2028
Figure 7. Basic Infusion
Figure 8. Therapeutic Infusion
Figure 9. Nutritious Infusion
Figure 10. Global Large Volume Parenteral (LVP) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Large Volume Parenteral (LVP) Market Size (2017-2028) & (US$ Million)
Figure 12. Global Large Volume Parenteral (LVP) Sales (2017-2028) & (M Units)
Figure 13. Large Volume Parenteral (LVP) Sales Share by Manufacturers in 2021
Figure 14. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Large Volume Parenteral (LVP) Players: Market Share by Revenue in 2021
Figure 16. Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2017-2022)
Figure 18. Global Large Volume Parenteral (LVP) Sales Market Share by Region in 2021
Figure 19. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2017-2022)
Figure 20. Global Large Volume Parenteral (LVP) Revenue Market Share by Region in 2021
Figure 21. U.S. Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Taiwan Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Large Volume Parenteral (LVP) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Large Volume Parenteral (LVP) by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Large Volume Parenteral (LVP)
Figure 45. Manufacturing Process Analysis of Large Volume Parenteral (LVP)
Figure 46. Large Volume Parenteral (LVP) Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’